Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone as Salvage Therapy in Relapsed/Refractory Multiple Myeloma
Clinical trial NCT03590652 · TERMINATED
Trial details
- NCT number
- NCT03590652
- Sponsor
- University of California, San Diego
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-17
- Primary completion
- 2025-07-02
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.